Needham & Company LLC Issues Pessimistic Forecast for Vital Farms (NASDAQ:VITL) Stock Price

Vital Farms (NASDAQ:VITL) had its price target lowered by analysts at Needham & Company LLC from $45.00 to $35.00 in a research report issued on Monday,Benzinga reports. The firm currently has a “buy” rating on the stock. Needham & Company LLC’s price objective would suggest a potential upside of 72.41% from the stock’s previous close.

Several other research firms have also issued reports on VITL. Jefferies Financial Group reaffirmed a “buy” rating and issued a $52.00 target price on shares of Vital Farms in a report on Wednesday, December 17th. TD Cowen reissued a “buy” rating on shares of Vital Farms in a report on Tuesday, January 20th. Morgan Stanley restated an “equal weight” rating and set a $24.00 price objective (down from $45.00) on shares of Vital Farms in a report on Friday, February 27th. Benchmark lowered shares of Vital Farms from a “buy” rating to a “hold” rating in a research report on Thursday, February 26th. Finally, DA Davidson set a $47.00 target price on shares of Vital Farms and gave the company a “buy” rating in a research note on Wednesday, December 17th. Nine analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $45.00.

Vital Farms Price Performance

Shares of NASDAQ:VITL opened at $20.30 on Monday. The company has a current ratio of 2.16, a quick ratio of 1.61 and a debt-to-equity ratio of 0.01. The stock has a market cap of $909.44 million, a PE ratio of 14.10 and a beta of 1.14. The stock’s fifty day simple moving average is $28.10 and its two-hundred day simple moving average is $35.59. Vital Farms has a 1-year low of $19.75 and a 1-year high of $53.13.

Vital Farms (NASDAQ:VITL) last posted its earnings results on Thursday, February 26th. The company reported $0.35 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.38 by ($0.03). Vital Farms had a return on equity of 20.69% and a net margin of 8.73%.The firm had revenue of $213.55 million during the quarter, compared to the consensus estimate of $212.83 million. During the same quarter in the previous year, the company earned $0.23 EPS. The business’s revenue was up 28.6% compared to the same quarter last year. As a group, analysts forecast that Vital Farms will post 1.11 EPS for the current fiscal year.

Insider Transactions at Vital Farms

In related news, insider Matthew Ohayer sold 25,000 shares of the company’s stock in a transaction that occurred on Friday, January 2nd. The shares were sold at an average price of $30.85, for a total transaction of $771,250.00. Following the sale, the insider directly owned 6,361,190 shares in the company, valued at approximately $196,242,711.50. This represents a 0.39% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, CEO Russell Diez-Canseco sold 16,734 shares of the firm’s stock in a transaction that occurred on Monday, December 15th. The stock was sold at an average price of $35.05, for a total transaction of $586,526.70. Following the completion of the transaction, the chief executive officer directly owned 649,684 shares of the company’s stock, valued at approximately $22,771,424.20. This trade represents a 2.51% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 66,734 shares of company stock valued at $2,092,227 in the last quarter. Company insiders own 21.30% of the company’s stock.

Institutional Investors Weigh In On Vital Farms

Hedge funds and other institutional investors have recently bought and sold shares of the business. Wasatch Advisors LP lifted its position in shares of Vital Farms by 80.2% during the second quarter. Wasatch Advisors LP now owns 2,074,803 shares of the company’s stock worth $79,921,000 after acquiring an additional 923,507 shares in the last quarter. William Blair Investment Management LLC bought a new stake in shares of Vital Farms during the 4th quarter valued at $25,534,000. Balyasny Asset Management L.P. raised its stake in shares of Vital Farms by 466.5% during the 4th quarter. Balyasny Asset Management L.P. now owns 503,894 shares of the company’s stock valued at $16,094,000 after purchasing an additional 641,394 shares during the period. Marshall Wace LLP lifted its holdings in Vital Farms by 97.4% during the 2nd quarter. Marshall Wace LLP now owns 1,234,008 shares of the company’s stock worth $47,534,000 after purchasing an additional 608,723 shares in the last quarter. Finally, Divisadero Street Capital Management LP boosted its stake in Vital Farms by 131.7% in the 3rd quarter. Divisadero Street Capital Management LP now owns 993,338 shares of the company’s stock worth $40,876,000 after purchasing an additional 564,711 shares during the period. Institutional investors own 98.59% of the company’s stock.

Key Vital Farms News

Here are the key news stories impacting Vital Farms this week:

• Positive Sentiment: Needham cut its price target from $45 to $35 but maintained a Buy rating, highlighting substantial upside from current levels and signaling continued conviction from that shop. Needham Lowers PT to $35
• Positive Sentiment: Mizuho lowered its target from $48 to $40 but kept an Outperform rating, implying they still see long-term upside despite cutting near-term assumptions. Mizuho Lowers PT to $40
• Positive Sentiment: Several outlets report a consensus analyst view of a “Moderate Buy,” which may support buying interest from investors who focus on the street’s average stance rather than individual downgrades. Analyst Consensus: Moderate Buy
• Neutral Sentiment: Morgan Stanley reiterated an Equal Weight rating, reflecting a neutral view that could temper volatility from more bullish or bearish shops. Morgan Stanley Equal Weight
• Neutral Sentiment: Market commentary is exploring whether the share-price slump creates a buying opportunity after recent weakness; such think-pieces can bring opportunistic buyers but don’t change fundamentals. Has VITL Become More Attractive?
• Negative Sentiment: Benchmark downgraded Vital Farms to Hold from Buy and removed its price target, citing a “volatile” Q1 outlook and tempered FY26 revenue growth — a direct reason for near‑term investor caution. Benchmark Downgrade to Hold
• Negative Sentiment: Rosen Law Firm announced an investigation into potential securities claims alleging Vital Farms may have issued materially misleading information; class‑action inquiries can increase downside risk (legal costs, distraction, sentiment hit). Rosen Law Firm PR Newswire GlobeNewswire

About Vital Farms

Vital Farms, traded on the NASDAQ under the symbol VITL, is a U.S.-based food company specializing in pasture-raised egg and dairy products. The company partners with a network of family farms across the United States to produce eggs, butter and related items under a certified humane, pasture-centric farming model. Vital Farms’ supply chain emphasizes animal welfare, environmental stewardship and transparent sourcing, appealing to consumers seeking ethically produced, high-quality ingredients.

Founded in 2007 and headquartered in Austin, Texas, Vital Farms began by marketing pasture-raised eggs to health- and ethically minded shoppers.